Idera Pharmaceuticals, Inc. (ACGN)
Market Closed
21 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 38
+0
+1.2895%
$
3.24M Market Cap
- P/E Ratio
- Div Yield
52,509 Volume
- Eps
$ 0.38
Previous Close Want to track ACGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Idera Pharmaceuticals, Inc. (ACGN) Statistics
Valuation metrics
Market Cap 3.24M
Enterprise value -8.24M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.67
Price/Book (mrq) 0.03
Enterprise Value/Revenue -1.7
Enterprise Value/EBITDA 0.71
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.36
52-Week high 16
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:17
Last split Date 18 Jan 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.8%
Operating margin -5.72%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.68%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.49
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.7
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 0.83%
Book value per share (mrq) 11.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
